November 16, 2012 - Friday

08:00 - 09:00 Registration
08:00 - 10:00 Courses and Workshop
  C-5: Neurocognitive tests in psychiatric disorders
Serhat Çıtak  
  C-6: Psychiatric treatments in the prenatal period
Nazan Aydın 
  C-7: Principles of psychotropic use in demantia
Engin Eker - Murat Emül
  C-8: From bipolarity to bipolar free state: An up to date, case based, interactive training of management of bipolar disorder-1 TAP MooD WorG
Erhan Kurt - Haluk Savaş - Numan Konuk - İbrahim Eren  
  W-1: What changed with arrival of buprenorphine+naloxone (Suboxone)?
İlhan Yargıç - Cüneyt Evren
  ICC-1: Interactive Case Conference: Case based learning in Psychiatry and Psychopharmacology
Serdar Dursun (University of Alberta, Canada)
10:00 - 11:00 Plenary Lecture
  PL-1: Anxiety disorders: What changed in DSM 5, what could be the implications in treatment?
Moderator: Oğuz Karamustafalıoğlu
Speaker: Joseph Zohar (Chaim Sheba Medical Center, Israel)
11:00 - 11:15 Tea & Coffee Break
11:15 - 12:45 Panel / Symposium
  PS-2: Diagnoses change but patients won’t: The paradox of classification
Discussant Moderators: Oğuz Karamustafalıoğlu, Alican Dalkılıç (Temple University, USA)
  Understanding the nature of psychiatric illnesses 
Serdar Dursun (University of Alberta, Canada)
  How will DSM 5 and ICD-11 effect treatment guidelines? 
Hakan Türkçapar
  Basis of classification changes with DSM 5
Joseph Zohar (Chaim Sheba Medical Center, Israel)
  Classification systems, neuroimaging data and biomarkers 
Ali Saffet Gönül
12:45 - 13:30 Lunch
13:30 - 14:30 Industry Supported Satellite Symposium-1  EGIS  egis
14:30 - 15:00 Tea & Coffee Break
15:00 - 16:15 Panel / Symposium
  PS-3: From neuroscience to clinical science: Recent developments in psychiatry
Discussant Moderators: Murad Atmaca - Serdar Dursun (University of Alberta, Canada)
  Understanding depression: New neurobiological and clinical perspectives
Feyza Arıcıoğlu
  Contribution of neuroimaging technologies to psychotropic drug development
Ali Saffet Gönül
  Changing and increasing role of GABA in psychiatric disorders
Hüseyin Günay
16:15 - 16:30 Tea & Coffee Break
16:30 - 17:30 Industry Supported Satellite symposium-2  JANSSEN  janssen
17:30 - 18:00 Tea & Coffee Break
18:30 - 19:30 Debate

Moderator: Serdar Dursun
(University of Alberta, Canada)
D-1: While preparing treatment guidelines; research data:

PROPONENT: Independent researches are important, industry supported researches are not safe
David Osser (Harvard Medical School, USA)

OPPONENT: Industry supported researches are important, industry supported researches are safe
Daniel Umbricht (University of Zurich, Switzerland)
19:30 - 20:00 Tea & Coffee Break
20:00 - 21:30 Courses
  C-9: Bedside cognitive tests Course
Işın Baral Kulaksızoğlu
  C-10: From bipolarity to bipolar free state: An up to date, case based, interactive training of management of bipolar disorder-2 TAP MooD WorG
Erhan Kurt - Haluk Savaş - Numan Konuk - İbrahim Eren  
  C-11: Mindfulness and acceptance based therapies: Practical applications for psychiatry
Kültegin Ögel
  C-12: Managing in the cases of ADHD and Bipolar Disorders, dependencies and other comorbidities in adults
Cengiz Başoğlu - Cengiz Tuğlu
  C-13: Social and psychological skills training in schizophrenia
Mustafa Yıldız